GLP-1 Prices
Across Europe Compared

Why prices vary across Europe

Unlike consumer goods, pharmaceutical prices in Europe are not set by a single market. Each country has its own pricing and reimbursement system, which means the same medication from the same manufacturer can cost significantly different amounts depending on where you buy it. The key factors driving these differences include:

• Government price negotiations: Countries like France (via the Comite Economique des Produits de Sante) and Spain (via the Interministerial Pricing Commission) negotiate directly with manufacturers, often securing lower prices in exchange for reimbursement status and guaranteed volume.
• Reference pricing: Many European countries set their prices based on the prices in other countries. The UK’s list price (set through the Voluntary Scheme for Branded Medicines Pricing and Access) influences — and is influenced by — prices elsewhere.
• Reimbursement status: Whether a drug is fully reimbursed, partially reimbursed, or only available privately affects the effective price patients pay out of pocket.
• VAT and dispensing fees: These vary by country and can add 5 to 25 per cent to the base price.
• Currency effects: Post-Brexit, exchange rate fluctuations between GBP and EUR affect price comparisons.

Price comparison: Ozempic (semaglutide for diabetes)

The following table compares approximate list or retail prices for Ozempic 1 mg pre-filled pen (4 weekly doses) across four major European markets. Prices are approximate, converted to GBP at April 2026 exchange rates, and may vary by pharmacy and region:

Price comparison: Wegovy (semaglutide for weight management)

Wegovy 2.4 mg (monthly supply, 4 pens) pricing varies more significantly because weight management is treated differently from diabetes across healthcare systems:

Price comparison: Mounjaro (tirzepatide)

Mounjaro availability and pricing in Europe is more varied because it received marketing authorisation more recently than Ozempic:

Medical tourism for GLP-1 medications

With price differences of 30 to 60 per cent, some UK patients have considered purchasing GLP-1 medications during European holidays or through cross-border pharmacy arrangements. Here is what you need to know:

Legal position for UK residents

• Personal importation: UK law permits individuals to bring back up to 3 months’ supply of a prescription medicine for personal use. You must have a valid prescription from a qualified medical practitioner (UK or overseas).
• Controlled drugs: GLP-1 RAs are not controlled drugs, so the stricter controlled substance rules do not apply.
• Post-Brexit: The UK is no longer part of the EU mutual recognition framework. EU prescriptions are not automatically valid in the UK, and vice versa. However, a prescription from an EU-qualified doctor is generally accepted for the purpose of personal importation.

Practical challenges

• Cold chain: GLP-1 injectable pens must be stored at 2–8°C before first use. Travelling with them requires a cool bag or insulated case and careful temperature management, especially during flights and transfers.
• Language barriers: Getting a prescription and purchasing from a pharmacy in a foreign language can be difficult. Pharmacists may not dispense to foreign patients without a local prescription in some countries.
• Ongoing monitoring: GLP-1 therapy requires regular medical follow-up (blood tests, dose adjustments, side-effect management). A one-off purchase abroad does not provide this.
• Cost of travel: When you factor in flights, accommodation, and time, the savings on a single month’s supply are typically minimal.
• Counterfeit risk: Purchasing from unregulated sources, whether online or in-person, carries the risk of counterfeit or improperly stored medication. The MHRA has issued multiple warnings about fake semaglutide pens.

Ordering from European online pharmacies

The EU has a common logo system for verified online pharmacies within member states. However, post-Brexit, these EU-regulated online pharmacies are not authorised to dispense to UK addresses. Specifically:

• EU online pharmacy regulations (Directive 2011/62/EU) do not extend to the UK
• Prescription-only medicines cannot legally be sold to UK residents without a valid UK prescription or equivalent
• Shipping temperature-sensitive injectables internationally is complex and may compromise the cold chain
• UK-based GPhC-registered online pharmacies remain the safest and most practical option for UK patients

How the UK compares globally

For broader context, the UK sits in the middle of global GLP-1 pricing:

Ways to reduce costs in the UK

Rather than looking abroad, UK patients have several options to reduce GLP-1 medication costs at home:

1. NHS route: If you meet the criteria for Wegovy on the NHS or Mounjaro via NHS specialist services, you pay only the standard prescription charge (£9.90 in England, free elsewhere in the UK).
2. Prepayment certificate: An NHS prescription prepayment certificate (PPC) costs £31.25 for 3 months or £111.60 for 12 months, saving money if you have multiple prescriptions.
3. Compare private clinics: Prices for private GLP-1 prescriptions vary significantly between weight loss clinics. Shop around and compare total costs including consultation fees.
4. Generic semaglutide: Generic semaglutide options may become available as patents expire, potentially reducing costs significantly.
5. Combination approach: Some patients start on a GLP-1 RA to achieve initial weight loss, then transition to lifestyle maintenance, reducing long-term medication costs.

Frequently asked questions

Why are GLP-1 prices different across Europe?

Each country negotiates independently with manufacturers. Government price controls, reimbursement policies, competitive landscape and VAT rates all contribute to differences of 30 to 60 per cent for the same product.

Is Ozempic cheaper in France or Spain than in the UK?

Generally, yes. France and Spain have government-regulated pricing that results in list prices approximately 30 to 50 per cent lower than UK private costs. However, for diabetes indications in the UK, NHS patients pay only the £9.90 prescription charge.

Can I bring GLP-1 medication back from a European holiday?

UK law allows up to 3 months’ supply for personal use with a valid prescription. Practical challenges include cold chain storage during travel, language barriers at pharmacies, and the need for ongoing UK-based medical monitoring.

Is GLP-1 medical tourism a good idea?

It is generally not recommended. Travel costs, cold chain logistics, lack of ongoing monitoring, and counterfeit risk typically outweigh the savings. UK-based NHS or regulated private options are safer and more practical for long-term treatment.

Can I order GLP-1 medication online from a European pharmacy?

Post-Brexit, EU online pharmacies are not authorised to dispense to UK addresses. The MHRA warns against purchasing from unverified online sources. UK-based GPhC-registered pharmacies are the safest option.

Sources

• MHRA — Guidance on personal importation of medicines (gov.uk)
• MHRA — Falsified medicines: reports and alerts (gov.uk)
• BNF — Semaglutide, Liraglutide, Tirzepatide monographs (bnf.nice.org.uk)
• Novo Nordisk — Ozempic and Wegovy pricing (novonordisk.com)
• Eli Lilly — Mounjaro pricing and availability (lilly.com)
• EMA — Directive 2011/62/EU on falsified medicines (ema.europa.eu)
• Vogler S et al. Pharmaceutical pricing and reimbursement in Europe. Generics and Biosimilars Initiative Journal 2023
• NHS Business Services Authority — Prescription charge and PPC information (nhsbsa.nhs.uk)
• NICE — Semaglutide for managing overweight and obesity (TA875)